Position history for SCHRODER INVESTMENT MANAGEMENT GROUP's holdings in Terns Pharmaceuticals, Inc.
SCHRODER INVESTMENT MANAGEMENT GROUP holds 99,360 shares of TERN (Terns Pharmaceuticals, Inc.), worth $4M as of 2025-Q4. The position was decreased (-54.4% shares). TERN represents 0.0% of SCHRODER INVESTMENT MANAGEMENT GROUP's portfolio.
Current Value
$4M
Current Shares
99,360
Total Value Change
+$2.3M
Total Shares Change
-155,324
Other major holders of TERN: BlackRock, Inc., MORGAN STANLEY, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, Avoro Capital Advisors LLC
Decreased |
| 99,360 |
-54.4% |
| $4M |
| 0.0% |
| $40.59 |
0 |
| 2025-Q3 | Decreased | 217,931 | -42.1% | $1.7M | 0.0% | $7.79 | 0 |
| 2025-Q2 | Unchanged | 376,204 | 0.0% | $1.4M | 0.0% | $3.83 | 0 |
| 2025-Q1 | Increased | 376,204 | +263.4% | $1.1M | 0.0% | $2.92 | 41 |
| 2024-Q4 | Unchanged | 103,508 | 0.0% | $572,399 | 0.0% | $5.53 | 0 |
| 2024-Q3 | Decreased | 103,508 | -59.4% | $884,993 | 0.0% | $8.55 | 0 |
| 2024-Q2 | New | 254,684 | - | $1.7M | 0.0% | $6.81 | 36 |